HALSA CARE GROUP LIMITED

HALSA CARE GROUP LIMITED

HCG REALISATIONS 2021 LIMITED - Company Information

Print Friendly Version

HALSA CARE GROUP LIMITED

Company Registration Number:
05149951 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2019

Period of accounts

Start date: 01 January 2019

End date: 31 December 2019

HALSA CARE GROUP LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2019

Balance sheet
Notes

HALSA CARE GROUP LIMITED

Balance sheet

As at 31 December 2019


Notes
2019
2018


£
£
Fixed assets
Tangible assets: 3 648,114 627,303
Investments: 4 154,814 3
Total fixed assets: 802,928 627,306
Current assets
Debtors:   260,095 549,087
Cash at bank and in hand: 68,382
Total current assets: 328,477 549,087
Creditors: amounts falling due within one year:   (459,207) (662,663)
Net current assets (liabilities): (130,730) (113,576)
Total assets less current liabilities: 672,198 513,730
Creditors: amounts falling due after more than one year:   (206,877) (293,890)
Total net assets (liabilities): 465,321 219,840
Capital and reserves
Called up share capital: 205 205
Revaluation reserve:5120,000120,000
Profit and loss account: 345,116 99,635
Shareholders funds: 465,321 219,840

The notes form part of these financial statements

HALSA CARE GROUP LIMITED

Balance sheet statements

For the year ending 31 December 2019 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 08 October 2020
and signed on behalf of the board by:

Name: Eamonn Byrne
Status: Director

The notes form part of these financial statements

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2019

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2019

2. Employees

2019 2018
Average number of employees during the period 42 49

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2019

3. Tangible Assets

Total
Cost £
At 01 January 2019 2,108,237
Additions 80,610
At 31 December 2019 2,188,847
Depreciation
At 01 January 2019 1,480,934
Charge for year 59,799
At 31 December 2019 1,540,733
Net book value
At 31 December 2019 648,114
At 31 December 2018 627,303

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2019

4. Fixed investments

Investments in subsidiaries 3Investment in indemnity policies 154811

HALSA CARE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2019

5. Revaluation reserve

2019
£
Balance at 01 January 2019 120,000
Surplus or deficit after revaluation 0
Balance at 31 December 2019 120,000